Your browser doesn't support javascript.
Influence of SARS-CoV-2 Variant B.1.1.7, Vaccination, and Public Health Measures on the Spread of SARS-CoV-2.
Dimeglio, Chloé; Milhes, Marine; Loubes, Jean-Michel; Ranger, Noémie; Mansuy, Jean-Michel; Trémeaux, Pauline; Jeanne, Nicolas; Latour, Justine; Nicot, Florence; Donnadieu, Cécile; Izopet, Jacques.
  • Dimeglio C; INSERM UMR1291-CNRS UMR5051, Toulouse Institute for Infectious and Inflammatory Diseases (INFINITy), 31300 Toulouse, France.
  • Milhes M; Virology Laboratory, Centre Hospitalier Universitaire de Toulouse, Hôpital Purpan, 31300 Toulouse, France.
  • Loubes JM; Genotoul-Genome & Transcriptome-Plateforme Génomique (GeT-PlaGe), US INRAe 1426, 31326 Castanet-Tolosan, France.
  • Ranger N; Institut de Mathématiques de Toulouse, Université de Toulouse, 31400 Toulouse, France.
  • Mansuy JM; Virology Laboratory, Centre Hospitalier Universitaire de Toulouse, Hôpital Purpan, 31300 Toulouse, France.
  • Trémeaux P; Virology Laboratory, Centre Hospitalier Universitaire de Toulouse, Hôpital Purpan, 31300 Toulouse, France.
  • Jeanne N; Virology Laboratory, Centre Hospitalier Universitaire de Toulouse, Hôpital Purpan, 31300 Toulouse, France.
  • Latour J; Virology Laboratory, Centre Hospitalier Universitaire de Toulouse, Hôpital Purpan, 31300 Toulouse, France.
  • Nicot F; Virology Laboratory, Centre Hospitalier Universitaire de Toulouse, Hôpital Purpan, 31300 Toulouse, France.
  • Donnadieu C; Virology Laboratory, Centre Hospitalier Universitaire de Toulouse, Hôpital Purpan, 31300 Toulouse, France.
  • Izopet J; Genotoul-Genome & Transcriptome-Plateforme Génomique (GeT-PlaGe), US INRAe 1426, 31326 Castanet-Tolosan, France.
Viruses ; 13(5)2021 05 12.
Article in English | MEDLINE | ID: covidwho-1227071
ABSTRACT
The spread of SARS-CoV-2 and the resulting disease COVID-19 has killed over 2.6 million people as of 18 March 2021. We have used a modified susceptible, infected, recovered (SIR) epidemiological model to predict how the spread of the virus in regions of France will vary depending on the proportions of variants and on the public health strategies adopted, including anti-COVID-19 vaccination. The proportion of SARS-CoV-2 variant B.1.1.7, which was not detected in early January, increased to become 60% of the forms of SARS-CoV-2 circulating in the Toulouse urban area at the beginning of February 2021, but there was no increase in positive nucleic acid tests. Our prediction model indicates that maintaining public health measures and accelerating vaccination are efficient strategies for the sustained control of SARS-CoV-2.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Observational study / Prognostic study Topics: Vaccines / Variants Limits: Humans Country/Region as subject: Europa Language: English Year: 2021 Document Type: Article Affiliation country: V13050898

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Observational study / Prognostic study Topics: Vaccines / Variants Limits: Humans Country/Region as subject: Europa Language: English Year: 2021 Document Type: Article Affiliation country: V13050898